{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-129777","form_type":"8-K","ticker":"DRIO","cik":"0001533998","company_name":"DarioHealth Corp.","filed_at":"2024-12-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.718906+00:00","generated_at":"2026-05-29T01:59:06.951406+00:00","sec_items":["1.01","2.03","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"DarioHealth raises ~$18.8M via preferred stock; amends Avenue loan to extend maturity","bullets":["Closed private placement of 7,055 Series D and 11,750 Series D-1 preferred shares at $1,000 each, raising $18.8M.","Preferred stock convertible at $0.73/share, subject to stockholder approval and a 19.99% beneficial ownership blocker.","Amended Avenue loan: extended interest-only period by 6 months, conditional on revenue milestone; maturity extended to Nov 1, 2027.","Proforma cash balance of $34M as of Q3 2024; company targets profitability run-rate by end of 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-129777","json":"https://secwatch.observer/filing/0001104659-24-129777.json","markdown":"https://secwatch.observer/filing/0001104659-24-129777.md","text":"https://secwatch.observer/filing/0001104659-24-129777.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1533998/000110465924129777/0001104659-24-129777-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1533998/000110465924129777/tm2431382d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T01:59:06.951406+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}